{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:24:33Z","timestamp":1793111073224,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974124"],"award-info":[{"award-number":["81974124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteogenesis imperfecta (OI) is a connective tissue disorder affecting the skeleton and other organs, which has multiple genetic patterns, numerous causative genes, and complex pathogenic mechanisms. The previous classifications lack structure and scientific basis and have poor applicability. In this paper, we summarize and sort out the pathogenic mechanisms of OI, and analyze the molecular pathogenic mechanisms of OI from the perspectives of type I collagen defects(synthesis defects, processing defects, post-translational modification defects, folding and cross-linking defects), bone mineralization disorders, osteoblast differentiation and functional defects respectively, and also generalize several new untyped OI-causing genes and their pathogenic mechanisms, intending to provide the evidence of classification and a scientific basis for the precise diagnosis and treatment of OI.<\/jats:p>","DOI":"10.1186\/s13023-023-02849-5","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T05:02:32Z","timestamp":1691557352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification"],"prefix":"10.1186","volume":"18","author":[{"given":"Hongjie","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-8881","authenticated-orcid":false,"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2849_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101\u201316. https:\/\/doi.org\/10.1136\/jmg.16.2.101","journal-title":"J Med Genet"},{"key":"2849_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1096\/fasebj.5.7.2010058","volume":"5","author":"H Kuivaniemi","year":"1991","unstructured":"Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1991;5:2052\u201360. https:\/\/doi.org\/10.1096\/fasebj.5.7.2010058","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"2849_CR3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00439-021-02302-2","volume":"140","author":"L Claeys","year":"2021","unstructured":"Claeys L, et al. Collagen transport and related pathways in Osteogenesis Imperfecta. Hum Genet. 2021;140:1121\u201341. https:\/\/doi.org\/10.1007\/s00439-021-02302-2","journal-title":"Hum Genet"},{"key":"2849_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/humu.22677","volume":"35","author":"S Symoens","year":"2014","unstructured":"Symoens S, et al. Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure. Hum Mutat. 2014;35:1330\u201341. https:\/\/doi.org\/10.1002\/humu.22677","journal-title":"Hum Mutat"},{"key":"2849_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00198-017-4224-8","volume":"29","author":"T Rolvien","year":"2018","unstructured":"Rolvien T, et al. A novel COL1A2 C-propeptide cleavage site mutation causing high bone mass osteogenesis imperfecta with a regional distribution pattern. Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA. 2018;29:243\u20136. https:\/\/doi.org\/10.1007\/s00198-017-4224-8","journal-title":"Osteoporos international: J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA"},{"key":"2849_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jmg.38.7.443","volume":"38","author":"JM Pace","year":"2001","unstructured":"Pace JM, Kuslich CD, Willing MC, Byers PH. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta. J Med Genet. 2001;38:443\u20139. https:\/\/doi.org\/10.1136\/jmg.38.7.443","journal-title":"J Med Genet"},{"key":"2849_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2018.12.111","volume":"509","author":"AL Scheiber","year":"2019","unstructured":"Scheiber AL, et al. Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta. Biochem Biophys Res Commun. 2019;509:235\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.111","journal-title":"Biochem Biophys Res Commun"},{"key":"2849_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/humu.21475","volume":"32","author":"K Lindahl","year":"2011","unstructured":"Lindahl K, et al. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat. 2011;32:598\u2013609. https:\/\/doi.org\/10.1002\/humu.21475","journal-title":"Hum Mutat"},{"key":"2849_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ajmg.a.62030","volume":"185","author":"J Steinle","year":"2021","unstructured":"Steinle J, Hossain WA, Lovell S, Veatch OJ, Butler MG. ADAMTSL2 gene variant in patients with features of autosomal dominant connective tissue disorders. Am J Med Genet: A. 2021;185:743\u201352. https:\/\/doi.org\/10.1002\/ajmg.a.62030","journal-title":"Am J Med Genet: A"},{"key":"2849_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41572-020-0194-9","volume":"6","author":"F Malfait","year":"2020","unstructured":"Malfait F, et al. The Ehlers-Danlos syndromes. Nat reviews Disease primers. 2020;6:64. https:\/\/doi.org\/10.1038\/s41572-020-0194-9","journal-title":"Nat reviews Disease primers"},{"key":"2849_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127:291\u2013304. https:\/\/doi.org\/10.1016\/j.cell.2006.08.039","journal-title":"Cell"},{"key":"2849_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral WA, et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet. 2007;39:359\u201365. https:\/\/doi.org\/10.1038\/ng1968","journal-title":"Nat Genet"},{"key":"2849_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011;7:540\u201357. https:\/\/doi.org\/10.1038\/nrendo.2011.81","journal-title":"Nat Rev Endocrinol"},{"key":"2849_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/hmg\/ddp481","volume":"19","author":"W Chang","year":"2010","unstructured":"Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC. Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet. 2010;19:223\u201334. https:\/\/doi.org\/10.1093\/hmg\/ddp481","journal-title":"Hum Mol Genet"},{"key":"2849_CR15","doi-asserted-by":"publisher","unstructured":"Besio R, et al. Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate. Dis Models Mech. 2019;12. https:\/\/doi.org\/10.1242\/dmm.038521","DOI":"10.1242\/dmm.038521"},{"key":"2849_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature05928","volume":"448","author":"M Yazawa","year":"2007","unstructured":"Yazawa M, et al. TRIC channels are essential for Ca2 + handling in intracellular stores. Nature. 2007;448:78\u201382. https:\/\/doi.org\/10.1038\/nature05928","journal-title":"Nature"},{"key":"2849_CR17","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1242\/dev.036798","volume":"136","author":"D Yamazaki","year":"2009","unstructured":"Yamazaki D, et al. Essential role of the TRIC-B channel in Ca2 + handling of alveolar epithelial cells and in perinatal lung maturation. Development. 2009;136:2355\u201361. https:\/\/doi.org\/10.1242\/dev.036798","journal-title":"Development"},{"key":"2849_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/circresaha.114.301816","volume":"114","author":"X Zhou","year":"2014","unstructured":"Zhou X, et al. Trimeric intracellular cation channels and sarcoplasmic\/endoplasmic reticulum calcium homeostasis. Circul Res. 2014;114:706\u201316. https:\/\/doi.org\/10.1161\/circresaha.114.301816","journal-title":"Circul Res"},{"key":"2849_CR19","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1210\/jc.2016-3766","volume":"102","author":"EA Webb","year":"2017","unstructured":"Webb EA, et al. Phenotypic spectrum in Osteogenesis Imperfecta due to mutations in TMEM38B: unraveling a Complex Cellular defect. J Clin Endocrinol Metab. 2017;102:2019\u201328. https:\/\/doi.org\/10.1210\/jc.2016-3766","journal-title":"J Clin Endocrinol Metab"},{"key":"2849_CR20","doi-asserted-by":"publisher","first-page":"11177","DOI":"10.1074\/jbc.M601369200","volume":"281","author":"T Koide","year":"2006","unstructured":"Koide T, et al. Specific recognition of the collagen triple helix by chaperone HSP47. II. The HSP47-binding structural motif in collagens and related proteins. J Biol Chem. 2006;281:11177\u201385. https:\/\/doi.org\/10.1074\/jbc.M601369200","journal-title":"J Biol Chem"},{"key":"2849_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajhg.2020.09.009","volume":"107","author":"FS van Dijk","year":"2020","unstructured":"van Dijk FS, et al. Interaction between KDELR2 and HSP47 as a key determinant in Osteogenesis Imperfecta caused by bi-allelic variants in KDELR2. Am J Hum Genet. 2020;107:989\u201399. https:\/\/doi.org\/10.1016\/j.ajhg.2020.09.009","journal-title":"Am J Hum Genet"},{"key":"2849_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00223-013-9723-9","volume":"93","author":"DR Eyre","year":"2013","unstructured":"Eyre DR, Weis MA. Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int. 2013;93:338\u201347. https:\/\/doi.org\/10.1007\/s00223-013-9723-9","journal-title":"Calcif Tissue Int"},{"key":"2849_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/humu.22362","volume":"34","author":"AM Barnes","year":"2013","unstructured":"Barnes AM, et al. Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations. Hum Mutat. 2013;34:1279\u201388. https:\/\/doi.org\/10.1002\/humu.22362","journal-title":"Hum Mutat"},{"key":"2849_CR24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/humu.22139","volume":"33","author":"AM Barnes","year":"2012","unstructured":"Barnes AM, et al. Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix. Hum Mutat. 2012;33:1589\u201398. https:\/\/doi.org\/10.1002\/humu.22139","journal-title":"Hum Mutat"},{"key":"2849_CR25","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/ajmg.a.62718","volume":"188","author":"GA Otaify","year":"2022","unstructured":"Otaify GA, et al. Bruck syndrome in 13 new patients: identification of five novel FKBP10 and PLOD2 variants and further expansion of the phenotypic spectrum. Am J Med Genet: A. 2022;188:1815\u201325. https:\/\/doi.org\/10.1002\/ajmg.a.62718","journal-title":"Am J Med Genet: A"},{"key":"2849_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011;88:362\u201371. https:\/\/doi.org\/10.1016\/j.ajhg.2011.01.015","journal-title":"Am J Hum Genet"},{"key":"2849_CR27","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/jbmr.487","volume":"26","author":"EP Homan","year":"2011","unstructured":"Homan EP, et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J bone mineral research: official J Am Soc Bone Mineral Res. 2011;26:2798\u2013803. https:\/\/doi.org\/10.1002\/jbmr.487","journal-title":"J bone mineral research: official J Am Soc Bone Mineral Res"},{"key":"2849_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbrc.2009.11.139","volume":"391","author":"T Akiyama","year":"2010","unstructured":"Akiyama T, et al. PEDF regulates osteoclasts via osteoprotegerin and RANKL. Biochem Biophys Res Commun. 2010;391:789\u201394. https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.139","journal-title":"Biochem Biophys Res Commun"},{"key":"2849_CR29","doi-asserted-by":"publisher","unstructured":"Zhytnik L, et al. IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in ukrainian and vietnamese patients. Hum Genomics. 2019;13. https:\/\/doi.org\/10.1186\/s40246-019-0209-3","DOI":"10.1186\/s40246-019-0209-3"},{"key":"2849_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jmedgenet-2012-101307","volume":"50","author":"F Rauch","year":"2013","unstructured":"Rauch F, et al. Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14\u00a0C > T mutation in all patients. J Med Genet. 2013;50:21\u20134. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101307","journal-title":"J Med Genet"},{"key":"2849_CR31","doi-asserted-by":"publisher","first-page":"116451","DOI":"10.1016\/j.bone.2022.116451","volume":"162","author":"G Hedjazi","year":"2022","unstructured":"Hedjazi G, et al. Alterations of bone material properties in growing Ifitm5\/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta. Bone. 2022;162:116451. https:\/\/doi.org\/10.1016\/j.bone.2022.116451","journal-title":"Bone"},{"key":"2849_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/gim.2017.115","volume":"20","author":"RB Keller","year":"2018","unstructured":"Keller RB, et al. Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively. Genet medicine: official J Am Coll Med Genet. 2018;20:411\u20139. https:\/\/doi.org\/10.1038\/gim.2017.115","journal-title":"Genet medicine: official J Am Coll Med Genet"},{"key":"2849_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/s0006-291x(02)00253-x","volume":"293","author":"Y Omori","year":"2002","unstructured":"Omori Y, et al. OASIS is a transcriptional activator of CREB\/ATF family with a transmembrane domain. Biochem Biophys Res Commun. 2002;293:470\u20137. https:\/\/doi.org\/10.1016\/s0006-291x(02)00253-x","journal-title":"Biochem Biophys Res Commun"},{"key":"2849_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ncb1213","volume":"7","author":"S Kondo","year":"2005","unstructured":"Kondo S, et al. OASIS, a CREB\/ATF-family member, modulates UPR signalling in astrocytes. Nat Cell Biol. 2005;7:186\u201394. https:\/\/doi.org\/10.1038\/ncb1213","journal-title":"Nat Cell Biol"},{"key":"2849_CR35","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1471-4159.2005.03596.x","volume":"96","author":"T Murakami","year":"2006","unstructured":"Murakami T, et al. Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress. J Neurochem. 2006;96:1090\u2013100. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03596.x","journal-title":"J Neurochem"},{"key":"2849_CR36","doi-asserted-by":"publisher","first-page":"10271","DOI":"10.1074\/jbc.REV120.012669","volume":"295","author":"J Ye","year":"2020","unstructured":"Ye J. Transcription factors activated through RIP (regulated intramembrane proteolysis) and RAT (regulated alternative translocation). J Biol Chem. 2020;295:10271\u201380. https:\/\/doi.org\/10.1074\/jbc.REV120.012669","journal-title":"J Biol Chem"},{"key":"2849_CR37","doi-asserted-by":"publisher","first-page":"11920","DOI":"10.1038\/ncomms11920","volume":"7","author":"U Lindert","year":"2016","unstructured":"Lindert U, et al. MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta. Nat Commun. 2016;7:11920. https:\/\/doi.org\/10.1038\/ncomms11920","journal-title":"Nat Commun"},{"key":"2849_CR38","doi-asserted-by":"publisher","unstructured":"Zhang B, et al. Effects of WNT1 c.110 T > C and c.505G > T mutations on osteoblast differentiation via the WNT1\/\u03b2-catenin signaling pathway. J Orthop Surg Res. 2021;16. https:\/\/doi.org\/10.1186\/s13018-021-02495-2","DOI":"10.1186\/s13018-021-02495-2"},{"key":"2849_CR39","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1002\/ajmg.a.40347","volume":"176","author":"S Alhamdi","year":"2018","unstructured":"Alhamdi S, et al. Heterozygous WNT1 variant causing a variable bone phenotype. Am J Med Genet: A. 2018;176:2419\u201324. https:\/\/doi.org\/10.1002\/ajmg.a.40347","journal-title":"Am J Med Genet: A"},{"key":"2849_CR40","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ajmg.a.61119","volume":"179","author":"S Nampoothiri","year":"2019","unstructured":"Nampoothiri S, et al. Ptosis as a unique hallmark for autosomal recessive WNT1-associated osteogenesis imperfecta. Am J Med Genet: A. 2019;179:908\u201314. https:\/\/doi.org\/10.1002\/ajmg.a.61119","journal-title":"Am J Med Genet: A"},{"key":"2849_CR41","doi-asserted-by":"publisher","first-page":"116400","DOI":"10.1016\/j.bone.2022.116400","volume":"160","author":"K Ludwig","year":"2022","unstructured":"Ludwig K, et al. Dominant osteogenesis imperfecta with low bone turnover caused by a heterozygous SP7 variant. Bone. 2022;160:116400. https:\/\/doi.org\/10.1016\/j.bone.2022.116400","journal-title":"Bone"},{"key":"2849_CR42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jmedgenet-2017-104999","volume":"55","author":"M Doyard","year":"2018","unstructured":"Doyard M, et al. FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta. J Med Genet. 2018;55:278\u201384. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104999","journal-title":"J Med Genet"},{"key":"2849_CR43","doi-asserted-by":"publisher","unstructured":"Watanabe T, et al. Fam46a regulates BMP-dependent pre-placodal ectoderm differentiation in Xenopus. Development. 2018;145. https:\/\/doi.org\/10.1242\/dev.166710","DOI":"10.1242\/dev.166710"},{"key":"2849_CR44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ajhg.2019.08.008","volume":"105","author":"S Moosa","year":"2019","unstructured":"Moosa S, et al. Autosomal-recessive mutations in MESD cause Osteogenesis Imperfecta. Am J Hum Genet. 2019;105:836\u201343. https:\/\/doi.org\/10.1016\/j.ajhg.2019.08.008","journal-title":"Am J Hum Genet"},{"key":"2849_CR45","doi-asserted-by":"publisher","first-page":"100051","DOI":"10.1016\/j.xhgg.2021.100051","volume":"2","author":"TT Tran","year":"2021","unstructured":"Tran TT, et al. Biallelic variants in MESD, which encodes a WNT-signaling-related protein, in four new families with recessively inherited osteogenesis imperfecta. HGG Adv. 2021;2:100051. https:\/\/doi.org\/10.1016\/j.xhgg.2021.100051","journal-title":"HGG Adv"},{"key":"2849_CR46","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/jbmr.4277","volume":"36","author":"J St\u00fcrznickel","year":"2021","unstructured":"St\u00fcrznickel J, et al. Compound heterozygous frameshift mutations in MESD cause a Lethal Syndrome Suggestive of Osteogenesis Imperfecta Type XX. J bone mineral research: official J Am Soc Bone Mineral Res. 2021;36:1077\u201387. https:\/\/doi.org\/10.1002\/jbmr.4277","journal-title":"J bone mineral research: official J Am Soc Bone Mineral Res"},{"key":"2849_CR47","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/jbmr.4011","volume":"35","author":"J Dubail","year":"2020","unstructured":"Dubail J, et al. Homozygous loss-of-function mutations in CCDC134 are responsible for a severe form of Osteogenesis Imperfecta. J bone mineral research: official J Am Soc Bone Mineral Res. 2020;35:1470\u201380. https:\/\/doi.org\/10.1002\/jbmr.4011","journal-title":"J bone mineral research: official J Am Soc Bone Mineral Res"},{"key":"2849_CR48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/ijmm.2017.3196","volume":"41","author":"B Yu","year":"2018","unstructured":"Yu B, et al. CCDC134 serves a crucial role in embryonic development. Int J Mol Med. 2018;41:381\u201390. https:\/\/doi.org\/10.3892\/ijmm.2017.3196","journal-title":"Int J Mol Med"},{"key":"2849_CR49","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/s0140-6736(15)00728-x","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino A, Marini JC. Osteogenesis imperfecta. Lancet (London England). 2016;387:1657\u201371. https:\/\/doi.org\/10.1016\/s0140-6736(15)00728-x","journal-title":"Lancet (London England)"},{"key":"2849_CR50","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.matbio.2007.06.005","volume":"26","author":"A Forlino","year":"2007","unstructured":"Forlino A, Kuznetsova NV, Marini JC, Leikin S. Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI. Matrix Biol. 2007;26:604\u201314. https:\/\/doi.org\/10.1016\/j.matbio.2007.06.005","journal-title":"Matrix Biol"},{"key":"2849_CR51","doi-asserted-by":"publisher","unstructured":"Garibaldi N, et al. Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Models Mech. 2022;15. https:\/\/doi.org\/10.1242\/dmm.049398","DOI":"10.1242\/dmm.049398"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02849-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T07:35:52Z","timestamp":1700379352000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02849-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2849"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02849-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"234"}}